• Shopping Cart
    There are no items in your cart
We noticed you’re not on the correct regional site. Switch to our AMERICAS site for the best experience.
Dismiss alert
Meet Inform Select. Always-on access to the Standards your organisation relies on. Explore Inform Select

17/30319534 DC : 0

NA

NA

Status of Standard is Unknown

BS ISO 13019 - TISSUE-ENGINEERED MEDICAL PRODUCTS - QUANTIFICATION OF SULPHATED GLYCOSAMINOGLYCANS (SGAG) FOR EVALUATION OF CHONDROGENESIS

Available format(s)

Hardcopy , PDF

Language(s)

English

£20.00
Excluding VAT

Foreword
1 Scope
2 Normative References
3 Terms and definitions
4 General and Principle
5 Apparatus
6 Preparation of parallel test samples from test
  samples
7 Procedure
8 Test report
9 Evaluation
Annex A (informative) - Flowchart of the overall procedure
        steps
Annex B (informative) - Reagents
Annex C (informative) - Procedure for pre-treatment
        (Option)
Annex D (informative) - Procedure for extraction
        of sGAG (Option)
Annex E (informative) - Example of test report format
        for sGAG measurement
Bibliography

BS ISO 13019.

Committee
RGM/1
DocumentType
Draft
Pages
20
PublisherName
British Standards Institution
Status
NA

ASTM F 2150 : 2013 : REDLINE Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products
ASTM F 2312 : 2011 : REDLINE Standard Terminology Relating to Tissue Engineered Medical Products
ISO 14155-2:2003 Clinical investigation of medical devices for human subjects — Part 2: Clinical investigation plans
ASTM F 2212 : 2011 : REDLINE Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
ISO 14155-1:2003 Clinical investigation of medical devices for human subjects — Part 1: General requirements
ASTM F 2383 : 2011 : REDLINE Standard Guide for Assessment of Adventitious Agents in Tissue Engineered Medical Products (TEMPs)
ASTM F 2027 : 2016 : REDLINE Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products
ISO 13022:2012 Medical products containing viable human cells — Application of risk management and requirements for processing practices
ISO/TS 10993-19:2006 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
ISO 10993-1:2009 Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
ISO 9000:2015 Quality management systems — Fundamentals and vocabulary
ISO 12891-1:2015 Retrieval and analysis of surgical implants — Part 1: Retrieval and handling

£20.00
Excluding VAT